Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies

In vitro amplified human leukocyte antigen (HLA)-haploidentical donor immune cell infusion (HDICI) is not commonly used in children. Therefore, our study sought to evaluate its safety for treating childhood malignancies. Between September 2011 and September 2012, 12 patients with childhood malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fei, Sun, Xiao-Fei, Li, Yong-Qiang, Zhen, Zi-Jun, Zheng, Hai-Xia, Zhu, Jia, Wang, Qi-Jing, Lu, Su-Ying, He, Jia, Wang, Juan, Pan, Ke, Cai, Rui-Qing, Chen, Yan, Weng, De-Sheng, Sun, Fei-Fei, Xia, Jian-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870850/
https://www.ncbi.nlm.nih.gov/pubmed/23706769
http://dx.doi.org/10.5732/cjc.012.10298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870850/
https://www.ncbi.nlm.nih.gov/pubmed/23706769
http://dx.doi.org/10.5732/cjc.012.10298

Ejemplares similares